Generex Biotechnology Corporation
GNBT · OTC
7/31/2020 | 7/31/2019 | 7/31/2018 | 7/31/2017 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$34,232 | -$11,007 | $35,949 | -$76,833 |
| Dep. & Amort. | $1,004 | $426 | $24 | $5 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $10,085 | $11,076 | $762 | $994 |
| Other Non-Cash | $14,953 | -$13,076 | -$39,028 | $74,663 |
| Operating Cash Flow | -$6,121 | -$9,574 | -$2,293 | -$1,170 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$5 | -$316 | -$9 | $0 |
| Net Acquisitions | $49 | $2,280 | $320 | $12 |
| Inv. Purchases | $0 | $0 | $0 | -$4,000 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $4,000 |
| Other Inv. Act. | $0 | $355 | -$320 | $0 |
| Investing Cash Flow | $45 | $2,319 | -$9 | $12 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $110 | $2,000,000 | $0 | $3,000 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $5,810 | $6,508,726 | $454 | $4,036 |
| Financing Cash Flow | $5,810 | $6,509 | $454 | $4,036 |
| Forex Effect | -$17 | -$1 | $15 | -$16 |
| Net Chg. in Cash | -$283 | -$748 | -$1,833 | $2,862 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $298 | $1,046 | $2,879 | $17 |
| End Cash | $15 | $298 | $1,046 | $2,879 |
| Free Cash Flow | -$6,126 | -$9,891 | -$2,302 | -$1,170 |